(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 4.84% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.66%.
Sanofi's revenue in 2024 is $51,518,478,260.On average, 5 Wall Street analysts forecast SNY's revenue for 2024 to be $66,631,703,754,070, with the lowest SNY revenue forecast at $64,215,020,098,102, and the highest SNY revenue forecast at $67,551,790,080,319. On average, 5 Wall Street analysts forecast SNY's revenue for 2025 to be $70,798,918,629,532, with the lowest SNY revenue forecast at $67,539,812,424,612, and the highest SNY revenue forecast at $72,770,633,008,406.
In 2026, SNY is forecast to generate $75,106,210,101,561 in revenue, with the lowest revenue forecast at $70,435,382,233,643 and the highest revenue forecast at $77,622,797,777,480.